Physician profile
John J Ball
NPI 1083609770
$2,526.05
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,952 · 2020: $57.81 · 2021: $113 · 2022: $43.52 · 2023: $129 · 2024: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.59 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,951.76 | 2019 | |
| Abbvie INC. | $214.17 | 2020-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Coopersurgical, INC. | $60.04 | 2023-2024 | Advincula Delineator Uterine Manipulator, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Pfizer INC. | $51.42 | 2024 | |
| Sumitomo Pharma America, INC. | $45.54 | 2024 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $44.17 | 2021-2024 | Exparel |
| Hologic Sales and Service, LLC | $26.35 | 2024 | Novasure, Myosure Tissue Removal Device |
| Exact Sciences Corporation | $22.04 | 2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $20.44 | 2020 | |
| Astellas Pharma US INC | $20.32 | 2023 | Veozah |
| Therapeuticsmd, INC. | $19.86 | 2021 | |
| Convatec INC. | $19.08 | 2024 | |
| Idorsia Pharmaceuticals US INC | $16.48 | 2023 | Quviviq |
| Amgen INC. | $14.38 | 2024 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.